A Pyrroloquinoline-Based Colchicine-Binding Site Inhibitor Drives Mitotic Arrest and Caspase-Dependent Apoptosis
ACS Omega · 10.11.2026 · 11 (44) · 68771-68790
DOI: 10.1021/acsomega.6c07991 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 29.10.2026. Verfasst von Tanya Garain und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Middle Tennessee State University, Murfreesboro, Tennessee 37132, United States. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Targeting the colchicine-binding site on tubulin represents a promising strategy for developing anticancer agents capable of overcoming drug resistance and alleviating limitations of current microtubule-targeting therapies. Building on the pharmacological potential of quinoline scaffolds, we designed pyrroloquinoline-based compounds aimed at targeting the colchicine-binding site on tubulin. A hypothesis-driven design strategy, guided by structure- and ligand-based molecular modeling, was employed to prioritize the designed molecules for strong predicted binding and pharmacophoric complementarity within the colchicine-binding site. A concise, efficient synthetic strategy was employed to access the target molecules, which were subsequently evaluated for antiproliferative activity across various cancer cell lines. The hit compounds reported in this paper, 4a and 5b, exhibited potent cytotoxicity, competitively inhibited the formation of the EBI−β-tubulin adduct, and induced pronounced disruption of the intracellular microtubule network. Compound 4a, in particular, consistently displayed significant biological activity, as mechanistic studies revealed that it triggers sustained G2/M phase arrest, suppresses proliferative signaling, and activates DNA damage–associated stress responses, followed by caspase-3 activation and PARP cleavage, indicative of caspase-dependent apoptosis. These results reinforce the utility of the quinoline scaffold for the development of colchicine-site microtubule inhibitors and highlight their potential in advancing new chemotherapeutic candidates.
Autor:innen und Institutionen
- Department of Chemistry, Middle Tennessee State University, Murfreesboro, Tennessee 37132, United States.
- Molecular Biosciences Program, Middle Tennessee State University, Murfreesboro, Tennessee 37132, United States.
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee 38163, United States.
- Department of Biology, Middle Tennessee State University, Murfreesboro, Tennessee 37132, United States.
ORCID-Profile: Shelby Waddell, Kevin L Bicker, April M Weissmiller, Wei Li, Souvik Banerjee
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- National Cancer Institute
- National Institute of General Medical Sciences
- University of Tennessee
Zitieren
APA
Garain, T., Waddell, S., Rai, P., Reed, C. N., Williams, B. D., Harrison, J. M., Clark, C. J., Zeleke, F., Barnes, S., Ma, D., Jessen, J. R., Bicker, K. L., Weissmiller, A. M., Li, W., & Banerjee, S. (2026). A Pyrroloquinoline-Based Colchicine-Binding Site Inhibitor Drives Mitotic Arrest and Caspase-Dependent Apoptosis. ACS Omega, 11(44), 68771-68790. https://doi.org/10.1021/acsomega.6c07991
Vancouver
Garain T, Waddell S, Rai P, Reed CN, Williams BD, Harrison JM, et al. A Pyrroloquinoline-Based Colchicine-Binding Site Inhibitor Drives Mitotic Arrest and Caspase-Dependent Apoptosis. ACS Omega. 2026;11(44):68771-68790. doi:10.1021/acsomega.6c07991
BibTeX
@article{Garain2026,
author = {Garain, Tanya and Waddell, Shelby and Rai, Prateek and Reed, Cinthia N and Williams, Brittney D and Harrison, Joy M and Clark, Christopher J and Zeleke, Faben and Barnes, Samara and Ma, Dejian and Jessen, Jason R and Bicker, Kevin L and Weissmiller, April M and Li, Wei and Banerjee, Souvik},
title = {A Pyrroloquinoline-Based Colchicine-Binding Site Inhibitor Drives Mitotic Arrest and Caspase-Dependent Apoptosis},
journal = {ACS Omega},
year = {2026},
volume = {11},
number = {44},
pages = {68771--68790},
doi = {10.1021/acsomega.6c07991}
}
EUVIMED